Dr. Mark Thomas Sonderman, MD

Dr. Sonderman practices at UW Medical Center - Montlake in Seattle, Washington, part of University of Washington.

Dr. Sonderman's NPI, 1578128658, was assigned on May 5, 2019. Dr. Sonderman holds Washington license MD61401126.

Dr. Sonderman's primary practice is UW Medical Center - Montlake, at 1959 NE Pacific St Box 356151, Seattle, WA 98195 in King County. The practice phone is (206) 598-3300.

Dr. Sonderman's primary practice is UW Medical Center - Montlake in Seattle, Washington, part of University of Washington. The medical group on file is UW Physicians. Dmand AI also links Dr. Sonderman to 1 more hospital and 1 hospital outpatient department, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Sonderman practices, 3 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Sonderman's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dmand AI has Dr. Sonderman's licenses on file in 2 states: Washington and Tennessee.

CMS data shows 38 Medicare services from Dr. Sonderman across 1 procedure code in 2024, for 31 Medicare patients. Medicare paid $2,620 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 31 Medicare patients who saw Dr. Sonderman in 2024. The largest group is 75 to 84, with 15 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 3.46, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Sonderman's median patient age at 62, with 32% women.

In 2024, Dr. Sonderman wrote 72 Medicare Part D claims for 24 patients. 85% of them were for generic drugs. CMS names the drug for 11 of them, across 1 drug with 11 or more claims each, at $40 in total drug cost. In 2022, CMS named 40 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. Sonderman for performance year 2024, reported through an alternative payment model (APM).

Dmand AI links 4 papers to Dr. Sonderman, published from 2018 to 2024. 2023 was the busiest year, with 2. Dr. Sonderman has published most often in JACC Adv. Dr. Sonderman's most frequent co-authors are Quinn S. Wells, MD, Aaron Weldon Aday, MD and Nazem W. Akoum, MD.

CMS Open Payments shows 1 general payment to Dr. Sonderman from 1 drug or device company in 2024. Education make up the largest share, 100% of the total. Abbott Laboratories paid the most, $133.